vTv Therapeutics Inc. (NASDAQ:VTVT) went down by -1.59% from its latest closing price compared to the recent 1-year high of $4.75. The company’s stock price has collected 2.06% of gains in the last five trading sessions. Press Release reported on 05/05/21 that vTv Therapeutics Announces 2021 First Quarter Financial Results and Provides Corporate Update
Is It Worth Investing in vTv Therapeutics Inc. (NASDAQ :VTVT) Right Now?
Plus, the 36-month beta value for VTVT is at -1.81. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for vTv Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $6.75. VTVT currently public float of 14.03M and currently shorts hold a 18.35% ratio of that float. Today, the average trading volume of VTVT was 5.33M shares.
VTVT’s Market Performance
VTVT stocks went up by 2.06% for the week, with a monthly jump of 2.90% and a quarterly performance of -0.40%, while its annual performance rate touched -14.78%. The volatility ratio for the week stands at 7.84% while the volatility levels for the past 30 days are set at 6.27% for vTv Therapeutics Inc.. The simple moving average for the period of the last 20 days is 2.12% for VTVT stocks with a simple moving average of 11.03% for the last 200 days.
Analysts’ Opinion of VTVT
Stifel, on the other hand, stated in their research note that they expect to see VTVT reach a price target of $1, previously predicting the price at $12. The rating they have provided for VTVT stocks is “Hold” according to the report published on April 10th, 2018.
ROTH Capital gave a rating of “Buy” to VTVT, setting the target price at $17 in the report published on March 08th of the previous year.
VTVT Trading at -3.33% from the 50-Day Moving Average
After a stumble in the market that brought VTVT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.79% of loss for the given period.
Volatility was left at 6.27%, however, over the last 30 days, the volatility rate increased by 7.84%, as shares surge +3.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.12% lower at present.
During the last 5 trading sessions, VTVT rose by +2.06%, which changed the moving average for the period of 200-days by +14.29% in comparison to the 20-day moving average, which settled at $2.43. In addition, vTv Therapeutics Inc. saw 33.33% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at VTVT starting from Nelson Rich S., who purchase 10,000 shares at the price of $2.86 back on Feb 26. After this action, Nelson Rich S. now owns 10,000 shares of vTv Therapeutics Inc., valued at $28,600 using the latest closing price.
Nelson Rich S., the Director of vTv Therapeutics Inc., purchase 50,000 shares at $2.86 during a trade that took place back on Feb 26, which means that Nelson Rich S. is holding 50,000 shares at $143,000 based on the most recent closing price.
Stock Fundamentals for VTVT
Current profitability levels for the company are sitting at:
- -184.78 for the present operating margin
The net margin for vTv Therapeutics Inc. stands at -132.51. Equity return is now at value 12.50, with -65.10 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 26.00, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 78.70 and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.13.